Stock screenerAll disclosures →
EDGAR →
URGN
Conviction 80HealthcareScan · Thu, Jun 25, 2026Tweezer top
URGN$34.30-3.16%
ResistanceSupportVol 14Insider sellVol MA14 630.61K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price34.30
Change-3.16%
Gap-0.08%
Rel volume0.67×
Avg volume636.32K
Avg $ vol19.06M
SMA 2030.16
SMA 5027.91
SMA 20022.41
Price vs 50+22.89%
Price vs 200+53.08%
MA stackbullish
50/200 cross—
Supertrendup · 30.43
RSI (14)69
MACD hist0.50
MACD crossbull · 7d
Stoch %K / %D82 / 90
ADX (14)44
+DI / −DI33 / 9
RSI divergence—
MACD divergence—
ATR %+4.86%
ADR %5.35%
52w high35.42
52w low12.96
From 52w high-3.16%
Above 52w low+164.66%
New 52w highNo
SqueezeOff
Bollinger width41.14%
%B0.83
Donchian pos82.34%
Donchian high36.08
Donchian low26.00
AVWAP (52w high)35.16
vs AVWAP high-2.43%
AVWAP (52w low)21.08
vs AVWAP low+62.68%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d0.67×
Avg vol (14d)630.61K
Avg vol (20d)636.32K
Avg $ vol (20d)19.06M
Market cap1.67B
RS 3m (vs SPY)+88.31%
RS 6m (vs SPY)+47.61%
RS line new highYes
Trend template8/8
Technical rank89.8
1 week+4.54%
1 month+16.43%
3 months+89.29%
6 months+45.46%
1 year+148.73%
YTD+51.03%
P/E-10.89
P/B-13.45
P/S15.22
P/FCF-10.27
EPS-4.96
Div yield—
ROE123.53%
ROA-60.50%
Debt/Eq-1.53
Current4.69
EV/EBITDA-14.06
Gross margin88.66%
Net margin-139.81%
Rev growth21.45%
EPS growth-20.98%
Price target36.63
Target upside6.79%
Analyst ratingBuy
Institutional96.20%
Ent. value1.75B
Revenue50.96M
Net income-23.57M
Gross profit46.82M
Free cash flow-162.73M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out48.72M
Employees291
ListedThu, May 4, 2017
Free float43.81M
Float %93.6%
Short interest6.92M
Days to cover11.1d
Short volume35.9%
Squeeze score57 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.42 · 4 est
Last EPS vs est−$0.47 vs −$0.56
Last surprise+16.1% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank89.8 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmTweezer top
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in URGN
No recent disclosed trades by Congress in URGN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in URGN · 5 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BUTITTA CYNTHIA M Director · Stock Option (right ot buy) · 2026-06-22 | Grant | 10K | — | 2026-06-22 | 2026-06-24 |
Belldegrun Arie Director · Stock Option (right ot buy) · 2026-06-22 | Grant | 20K | — | 2026-06-22 | 2026-06-24 |
BUTITTA CYNTHIA M Director · Restricted Stock Unit · 2026-06-22 | Grant | 8K | — | 2026-06-22 | 2026-06-24 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-06-08 | Exercise | 10K | — | 2026-06-08 | 2026-06-09 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-06-08 | Sell | 5.22K | $143K | 2026-06-08 | 2026-06-09 |
Schoenberg Mark Chief Medical Officer · Restricted Stock Units · 2026-06-08 | Exercise | 10K | $0 | 2026-06-08 | 2026-06-09 |
Robinson James A. Jr. Director · ordinary shares · 2026-05-26 | Exercise | 2K | — | 2026-05-26 | 2026-05-27 |
Robinson James A. Jr. Director · Restricted Stock Unit · 2026-05-26 | Exercise | 2K | $0 | 2026-05-26 | 2026-05-27 |
Schoenberg Mark Chief Medical Officer · Ordinary Shares · 2026-05-08 | Sell | 10K | $300K | 2026-05-08 | 2026-05-11 |
SEC filings
EDGAR filings in URGN · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.